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Abstract
The first biomimetic enantioselective total synthesis of (−)-communesin F based on a late-stage 
heterodimerization and aminal exchange is described. Our synthesis features the expedient 
diazene–directed assembly of two advanced fragments to secure the congested C3a–C3a′ linkage 
in three steps, followed by a highly efficient biogenetically inspired aminal reorganization to 
access the heptacyclic communesin core in only two additional steps. Enantioselective syntheses 
of the two fragments were developed, with highlights including the catalytic asymmetric 
halocyclization and diastereoselective oxyamination reactions of tryptamine derivatives, a 
stereoselective sulfinimine allylation, and an efficient cyclotryptamine–C3a-sulfamate synthesis by 
either a new silver–promoted nucleophilic amination or a rhodium–catalyzed C–H amination 
protocol. The versatile synthesis of the fragments, their stereocontrolled assembly, and the 
efficient aminal–exchange as supported by in situ monitoring experiments, in addition to the final 
stage N1′-acylation of the communesin core provide a highly convergent synthesis of (−)-
communesin F.
 Introduction
The communesin alkaloids are a family of structurally complex natural products isolated 
from various marine and terrestrial Penicillium fungi, which have been shown to possess 
insecticidal and antiproliferative activities as well as significant cytotoxicity against 
lymphocytic leukemia.1,2 The core structures of these alkaloids share a unique heptacyclic 
skeleton containing two aminals and at least five stereogenic centers, of which two are 
vicinal and quaternary (Figure 1). This exquisite structural complexity coupled with an array 
of interesting biological properties has prompted investigations directed towards the 
chemical synthesis of these alkaloids,2 culminating in innovative solutions for the total 
synthesis of (±)-communesin F (1) by Qin,3 Weinreb,4 and Funk,5 in addition to a formal 
synthesis by Stoltz.6 To date, Ma’s total synthesis of (−)-communesin F (1)7 remains the 
only enantioselective solution for this archetypical alkaloid. As an outgrowth of our 
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investigations in the area of calycanthaceous alkaloids,8,9 we sought to develop a unified and 
convergent approach to the communesin alkaloids. We drew inspiration from a speculated 
biogenesis involving the stereocontrolled oxidative union of two dissimilar tryptamine 
derivatives followed by reorganization of a C3a–C3a′ linked heterodimer,10,11,12,13 
reminiscent of the pathways leading to the related calycanthoids.12,14, While our 
biosynthetic considerations were purely hypothetical at the outset of this synthesis 
campaign, Houk, Garg, and Tang have recently disclosed15 incisive biosynthetic and 
computational studies that echo the key transformations developed in our synthesis. Herein, 
we present the shortest enantioselective total chemical synthesis of (−)-communesin F (1) 
with late-stage chemistry that fortuitously parallels the latest insights15b and hypotheses 
concerning the biogenesis of these alkaloids.
The expectation that the biosynthesis of calycanthaceous family of alkaloids14 has relevance 
to the biogenesis of the communesins stems from the structural similarity of these alkaloids 
and their precursors (Scheme 1). Woodward and Robinson independently proposed that the 
biogenesis of the calycanthoids is predicated on the oxidative homodimerization of N-
methyl tryptamine (10) to form indolenine dimers, such as 13, which can give rise to five 
constitutional isomers upon reorganization of the two aminal functional groupings.10–11 In 
the illustrative case of indolenine dimer 13 (Scheme 1), amine cyclization via path-a results 
in (+)-chimonanthine (16), whereas an alternative cyclization via path-b, perhaps through the 
intermediacy of hexacycle 14, affords the isomeric alkaloid (−)-calycanthine (17). Indeed, 
the equilibration of (+)-chimonanthine (16) to (−)-calycanthine (17) under acidic aqueous 
conditions (16:17=15:85)8a,16 demonstrates the potential dynamic nature of these polycyclic 
structures. Anticipating a related biogenesis for the communesins, we expected the 
heterodimeric intermediate 15 to undergo a similar dynamic reorganization to afford 
heptacycle 18. Consistent with this hypothesis, an enzyme capable of the oxidative coupling 
of tryptamines and Penicillium fungal alkaloid (−)-aurantioclavine (12)17,18 has been 
identified that leads to the formation of the communesin core or an isomeric heptacycle 
depending on the tryptamine.15b We began our studies with the recognition that successful 
implementation of a biomimetic strategy for the efficient synthesis of these alkaloids 
requires the directed and stereocontrolled union of two dissimilar fragments followed by 
selective reorganization of a C3a–C3a′ linked heterodimer to a single constitutional isomer 
consistent with the communesin skeleton 18.
 Results and Discussion
As illustrated in our retrosynthetic analysis of (−)-communesin F (1, Scheme 2), strict 
adherence to the central paradigm in the biogenesis of calycanthaceous alkaloids focused 
our design on the efficient assembly and reorganization of a key heterodimeric intermediate 
20. Prompted by our strategy for directed heterodimerization of cyclotryptamines,19 we 
envisioned hexacycle 20 (Scheme 2) to serve as a surrogate for the hypothetical biosynthetic 
intermediate 15 (Scheme 1). We anticipated the N8′-sulfonamide would guide the opening 
of the C8a′-aminal to present the C8a′-imine for N1-addition. Furthermore, we projected the 
ionization of the C8a-nitrile would offer the C8a-imininium ion needed for aminal formation 
via N8′-addition. The challenging C3a–C3a′ linkage of heterodimer 20 required a directed 
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and stereocontrolled union of a cyclotryptamine fragment 21 and aurantioclavine derivative 
22 to simultaneously secure the two critical quaternary stereocenters. Our diazene-based 
strategy for directed complex fragment assembly19 provided the essential framework to 
explore this exciting and convergent approach to (−)-communesin F (1). While we were 
confident the C8a′-stereochemisry of the cyclotryptamine moiety would guide the desired 
C3a′-stereochemical outcome in this union, we were intrigued by the potential level of 
stereochemical control expected at C3a during carbon–carbon bond formation. We 
envisioned the synthesis of complex heterodimeric diazene 23 from tricyclic amines 24 and 
25 as tryptamine–surrogates necessary for securing the C3a–C3a′ linkage (Scheme 2).
Our synthesis of (−)-communesin F (1) commenced with the preparation of the two key 
tricyclic amines 24 and 25 required for the assembly of critical diazene 23 (Scheme 2). We 
pursued two approaches to the synthesis of the C3a′-amino cyclotryptamine 25 and the 
corresponding sulfamate 27 (Scheme 3). In the first approach, motivated by efficient access 
to enantiomerically enriched C3a′-halocyclotryptamine derivatives,20a we envisioned a 
nucleophilic C3a′-amination (Scheme 4) reminiscent of our Friedel-Crafts strategy for C3a-
derivatization developed in the context of our naseseazine alkaloid total synthesis.21 Our 
second approach to amine 25 relied on Du Bois amination22 of cyclotryptamine 28 to secure 
the sulfamate 27 (Scheme 5).19c
Given the versatility of cyclotryptamine–sulfamates as precursors to the corresponding 
mixed sulfamides,19c we developed an efficient synthesis to access sulfamate (+)-31 and 
related derivatives starting with C3a′-bromocyclotryptamine (+)-29 (Scheme 4). 
Enantioselective bromocyclization20a of Nβ-Cbz-N1-benzenesulfonyltryptamine catalyzed 
by (S)-3,3′-bis(2,4,6-triisopropylphenyl)-1,1′-binaphthyl-2,2′-diyl hydrogenphosphate 
(TRIP)20b afforded C3a′-bromocyclotryptamine (+)-29 in 93% yield and 96% enantiomeric 
excess.23 Significantly, electrophilic activation21 of the tricyclic bromide (+)-29 in the 
presence of 2,6-difluorophenylsulfamate22 provided the desired sulfamate (+)-31 in 63% 
yield (Scheme 4). The use of 2,6-difluorophenylsulfamate as a nucleophile to trap an 
intermediate C3a′-electrophile 30 provides a new and expedient route for the directed 
synthesis of complex diazenes.19c While this new single-step synthesis of C3a′-sulfamates 
from the corresponding C3a′-bromides offers a concise solution to the desired precursors, its 
utility in conversion of the more acid sensitive tert-butyl carbamate substrate 26 to sulfamate 
27 gave capricious and inferior outcomes (~50% yield).
Our alternate approach for the synthesis of tert-butylcarbamate derivative 27 relied on the C–
H amination chemistry illustrated in Scheme 5. Mild reduction of bromocyclotryptophan 
(+)-32 provided the desired C3a′–H cyclotryptophan (+)-33 in 95% yield.23 Subsequent 
decarboxylation furnished cyclotryptamine (+)-28 in 69% yield. Under optimal conditions, a 
Rh-catalyzed C–H amination22 of cyclotryptamine (+)-28 afforded the desired sulfamate 
(+)-27 in 39% yield after recrystallization.24 This three-step sequence efficiently generated 
gram quantities of (+)-27 from the readily available bromocyclotryptophan (+)-32 as an 
activated form of C3a′-aminocyclotryptamine 25 (Scheme 2) that is ready for coupling with 
tricyclic amine 24 for diazene synthesis.
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With an expedient synthesis of sulfamate (+)-27 available, we turned our attention to the 
synthesis of the tricyclic amine 24 (Scheme 6). While syntheses of aurantioclavine (12) have 
been reported,18 the synthesis of a derivative needed to mimic fragment 22, necessary for 
our biomimetic approach to (−)-communesin F (1), has not been described. As a result, we 
sought to develop an enantioselective synthesis of a tricycle reminiscent of alkaloid 12 that 
would allow for implementation of our synthetic strategy (Scheme 2). The tricyclic 
aminonitrile 24 offered the necessary C3a-amine for diazene synthesis and the C8a-
aminonitrile to allow for mild generation of the corresponding C8a-iminium ion needed for 
aminal synthesis. We developed two strategies to access the key intermediate 24 as 
illustrated in Scheme 6. The first strategy involved tryptamine 34 as the substrate for the 
application of Yoon’s oxyamination chemistry,25 while the second strategy utilized tert-butyl 
sulfinimine 35 and Ellman’s asymmetric allylation26 of such substrates.27
The oxyamination25 route to aminonitrile 24 commenced with a Mizoroki-Heck reaction of 
bromoindole (−)-3423 with 1,1-dimethylallyl alcohol to provide allylic alcohol (−)-36. 
Despite early reservations regarding possible competing C9-C10-oxyamination25b-f of vinyl 
indole (−)-36 in place of the desired C3a-C8a-oxyamination, we observed higher levels of 
diastereoselection28 for the oxyamination of the more advanced substrate (−)-36 (Scheme 7). 
The use of stoichiometric copper(II) chloride facilitated the reaction and gave oxazoline 
(−)-37 in 68% yield (89:11 dr). Treatment of alcohol (−)-37 with 
bis(acetonitrile)dichloropalladium(II) in acetonitrile to form the desired azepane (85% 
yield)23 followed by removal of the chiral auxiliary (88% yield) provided the desired 
indoline (−)-38. The formylation of indoline (−)-38 to give formamide (−)-39 (83% yield) 
followed by mild reduction with sodium borohydride in the presence of trifluoroacetic acid 
gave the desired N-methylindoline (−)-40 (73% yield).29 Exposure of sulfonamide (−)-40 to 
thiophenol and potassium carbonate led to removal of the para-nitrobenzenesulfonyl group 
and the isolation of the stable oxazolidine (−)-41 in 70% yield. Given the propensity of 
oxazolidine (−)-41 and aminonitrile (+)-24 toward elimination of the C3a-amino group 
under strongly acidic or basic conditions, we developed mild hydrolysis conditions to allow 
for cyanation of a transient C8a-hemiaminal leading to aminonitrile (+)-24 in 52% yield in 
addition to the C8a-epimer (26%). While this approach provides flexibility for the late-stage 
introduction of various N8-substituents and establishes the C3a-configuration, the challenge 
in unraveling the oxazolidine substructure prompted our investigation of an alternate route to 
aminonitrile (+)-24 (Scheme 6) involving C3a–C bond formation.
Our alternative synthesis of aminonitrile (+)-24 began with the diastereoselective 
allylation26 of N8-methyl sulfinimine (−)-42 (Scheme 8) to provide allyl oxindole (+)-43 in 
78% yield and with excellent diastereopurity after trituration of the crude addition product 
with hexane (>98:2 dr).23 In contrast to our first approach to aminonitrile (+)-24, the 
placement of the chiral auxiliary on the C3a-substituent enabled our use of the N8-methyl 
variant of sulfinimine 35 (Scheme 6).23 Ozonolysis of alkene (+)-43 followed by a reductive 
work-up afforded the primary alcohol (+)-44 in 79% yield. The alcohol (+)-44 was then 
converted to tert-butyl carbamate (+)-45 in 82% yield via a Mitsunobu displacement and 
subsequent in situ desulfonylation. The allylic alcohol needed for synthesis of the azepane 
substructure was introduced via a Stille vinylation to furnish allylic alcohol (−)-46 in 88% 
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yield.30 A palladium-catalyzed allylic amination provided azepane (−)-47 in 81% yield as a 
single diastereomer. The stereochemistry at C3a and C9 of azepane (−)-47 was confirmed 
unambiguously through analysis of the crystal structure of the corresponding amine (+)-48 
(Scheme 8). We then focused on development of conditions for mild and efficient conversion 
of oxindole (−)-47 to the desired aminonitrile (+)-24. Partial reduction of oxindole (−)-47 
with lithium borohydride afforded a mixture of C8a-hemiaminal diastereomers that were too 
labile for isolation. Direct treatment of the crude hemiaminal with trimethylsilyl cyanide in 
hexafluoroisopropanol31 furnished the desired aminonitrile (+)-49 in 60% yield32 and the 
easily separable minor C8a-epimer (30%).23 Methanolysis of the tert-butyl sulfinamide 
(+)-49 provided the desired amino-azepane (+)-24 in 64% yield.33 The C8a-aminonitrile 
proved to be an ideal trigger for late stage hemiaminal formation34 while providing adequate 
stability for the implementation of an efficient fragment assembly. We anticipate future 
adaptation of this robust synthetic route to other N8-variants of azepane (+)-24 via judicious 
N8-substitution of sulfinimine 35.
After developing versatile syntheses of both essential fragments, we next examined the 
union of azepane (+)-24 and cyclotryptamine (+)-27 to introduce the critical C3a–C3a′ bond. 
Dissolution of the two fragments in tetrahydrofuran in the presence of 4-(N,N-
dimethylamino)pyridine afforded sulfamide (+)-50 in 80% yield on gram-scale (Scheme 
9).23 Consistent with our prior observation, the oxidation of sterically shielded sulfamides 
containing electron-rich arenes, such as the N-methyl aniline substructure of sulfamide 
(+)-50, suffers from competitive arene-halogenation. After extensive experimentation, we 
discovered the unique ability of tertiary N-chloroamides to effect chemoselective oxidation 
of sulfamide (+)-50 to the corresponding diazene (Scheme 9) without competitive 
arenehalogenation. Exposure of sulfamide (+)-50 to N-chloro-N-methylbenzamide (6 equiv) 
in conjunction with polystyrene-bound 2-tert-butylimino-2-diethylamino-1,3-dimethyl-
perhydro-1,3,2-diazaphosphorine (BEMP) in methanol provided the desired diazene (+)-23 
in 57% yield.35 Photoexcitation and expulsion of dinitrogen from a thin film of diazene 
(+)-23, followed by radical combination of the resulting cyclotryptamine 21 and azepane 22 
(Scheme 2), afforded the desired heterodimer (+)-51 in 39% yield as a single diastereomer.36 
While the stereochemical outcome at C3a′ of heterodimer (+)-51 is anticipated,19 the 
remarkable diastereoselection at C3a is notable and likely due to the confluence of a rapid 
radical combination step and the additional stereoinduction imposed by the C8a-nitrile.23,37 
Importantly, our diazene-based strategy for directed complex fragment assembly allowed for 
the stereoselective construction of the critical C3a–C3a′ linkage, securing the corresponding 
vicinal quaternary stereocenters.
With the successful union of the tricyclic–azepane and the cyclotryptamine fragments at 
hand, we turned our attention to the development of a biogenetically inspired aminal 
reorganization of heterodimer (+)-51 to access the heptacyclic communesin core. Informed 
by experience in rearrangement of the calycanthaceous alkaloids,8,14 we recognized the 
significance in the judicious choice of reaction conditions for the planned transformation due 
to the sensitive nature of the C3a–C3a′ linkage. Furthermore, we anticipated that an 
appropriate sequence of amine unveiling would maximize efficiency for the desired aminal 
exchange. We projected that unveiling the N1- and N1′-amines of heterodimer (+)-51 would 
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allow opening of the C8a′ aminal with the benzenesulfonamide as the leaving group, thus 
allowing rapid trapping of the C8a′-imine of intermediate 19 en route to heptacycle 52. 
Treatment of heterodimer (+)-51 with scandium trifluoromethanesulfonate in 
trifluoroethanol provided the desired heterodimer (+)-20 by selective removal of the tert-
butyl carbamates while preserving the sensitive C8a-aminonitrile (Scheme 10). The electron-
withdrawing N8′-sulfonamide enabled our examination of basic conditions to selectively 
open the cyclotryptamine substructure. In the event, treatment of heterodimer (+)-20 with 
lithium tert-butoxide in methanol provided clean and complete conversion to the desired 
heptacyclic structure 52 within 1 h at 50° C as observed by in situ 1H-NMR spectroscopy.23 
Significantly, only the desired heptacycle 52 was formed in preference to other constitutional 
isomers.15b Methanol was found to be an excellent solvent38 for this transformation, likely 
due to its ability to stabilize reactive intermediates as the corresponding O-alkyl-
hemiaminals. Although intermediate 52 could be observed by in situ 1H NMR 
spectroscopy,23 this compound did not show sufficient stability for isolation. We suspect this 
may be due to the sensitive nature of the C8a′-aminal of heptacycle 52, which upon 
reversible opening to the C8a′-imine increases the lability of the C3a–C3a′ bond. As a 
testimony to the sensitivity of the C3a–C3a′ linkage of heterodimer (+)-20, simple heating of 
a derivative (C8a-OMe instead of C8a-CN) in acetonitrile-d3 at 80 °C predominantly led to 
fragmentation.39 Indeed, treatment of the basic solution of heptacycle 52 with pyridinium p-
toluenesulfonate to quench the alkoxides, followed by addition of acetic anhydride afforded 
the N1′-acetyl derivative (−)-53 in 82% overall yield.23 A final-step unveiling of the N8′-
amine was accomplished by treatment of (−)-53 with sodium amalgam to provide (−)-
communesin F (1) in 83% yield. All 1H and 13C NMR data as well as optical rotation 
(observed [α]D24 = −249, c = 0.13, CHCl3; literature [α]D20 = −264, c = 0.34, CHCl3),1c,23 
for our synthetic (−)-communesin F (1) were in agreement with literature data.
 Conclusion
A highly convergent enantioselective total synthesis of (−)-communesin F (1) with late-stage 
chemistry that parallels the latest insights15 and hypotheses concerning the biogenesis of 
these alkaloids is described. Our expedient synthesis involves the union of fragments (+)-24 
and (+)-27 to provide complex sulfamide (+)-50 on gram-scale. This advanced intermediate 
is converted to alkaloid (−)-1 in only five additional steps (Schemes 9 and 10) which include 
the application of our diazene–directed fragment assembly strategy to secure the congested 
C3a–C3a′ linkage, and a guided biomimetic rearrangement to selectively provide the 
heptacyclic core of these alkaloids. Highlights of our synthesis include an efficient 
cyclotryptamine–C3a-sulfamate synthesis by either a new silver–promoted nucleophilic 
amination or rhodium–catalyzed C–H amination protocol, application of catalytic 
asymmetric halocyclization and diastereoselective oxyamination reactions in complex 
settings, a stereoselective sulfinimine allylation, and efficient assembly and utility of a richly 
functional diazene for complex fragment coupling. The successful implementation of this 
synthetic strategy and the versatile synthesis of the fragments, along with a final stage 
acylation of the communesin core provide a foundation for a unified synthetic route to 
access structurally related complex alkaloids and derivatives.
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(32). The C8a-configuration of the major diastereomer was determined by nOe analysis of a derivative.
(33). Exposure of the C8a-epimer to the same conditions resulted in only 22% yield of the desired 
epimeric aminonitrile.
(34). For representative examples of related use of aminonitriles in synthesis, see: Overman LE, 
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recovered (+)-50 (17%), and a tricyclic cyanoindole side product (25%) arising from E2-
elimination of C3a-sulfamide.
(36). The formation of the tricyclic cyanoindole (~47%) and a C3a′-H cyclotryptamine 28 (~51%) as 
disproportionation products is reflective of the significant steric barrier for C3a–C3a′ bond 
formation and competitive C8a-H abstraction.
(37). Calculations suggest the C8a-CN provides 3.8 kcal/mol preference for the desired C3a 
stereochemical outcome.
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product (−)-53 in 52% yield.
(39). Experiment conducted over 13 h in the absence of acid or base promoter. We reason that 
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Figure 1. 
The Structure of Communesin Alkaloids
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Scheme 1. 
Comparison of the Bond Formations in the Biogenesis of Structurally Related Dimeric 
Alkaloids
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Scheme 2. 
Biogenetically Inspired Retrosynthetic Analysis of (−)-Communesin F (1)
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Scheme 3. 
Strategies for Synthesis of Tricycle 27
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Scheme 4. 
Concise Synthesis of Sulfamate (+)-31a
aReagents and conditions: (a) AgSbF6, 2,6-di-tert-butyl-4-methylpyridine, 2,6-
difluorophenylsulfamate, CH2Cl2, 23 °C, 63%.
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Scheme 5. 
Gram-scale Synthesis of Sulfamate (+)-27a
aReagents and conditions: (a) (Me3Si)3SiH, Et3B, air, 23 °C, >99:1 dr; (b) (i) KOH (aq.), 
MeOH, CH2Cl2, 23 °C, (ii) N,N,N′,N′-tetramethylchloroformamidinium 
hexafluorophosphate, thiopyridine N-oxide, 4-(N,N-dimethylamino)pyridine, Et3N, THF; t-
BuSH, hν, 23 °C; (c) Rh2(esp)2, H2NSO3Ar, PhI(OAc)2, Ph(CH3)2CCO2H, MgO, 5Å-MS, 
i-PrOAc, 23 °C; Ar=2,6-difluorobenzene.
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Scheme 6. 
Strategies for Synthesis of Tricycle 24
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Scheme 7. 
Oxyamination Approach to Tricycle (+)-24a
aReagents and conditions: (a) 1,1-dimethylallyl alcohol, Pd(OAc)2, P(o-tol)3, Et3N, MeCN, 
95 °C; (b) 3,3-dimethyl-2-(p-nitrobenzenesulfonyl)-1,2-oxaziridine, CuCl2, n-Bu4NCl, 
CHCl3, 21 °C, 89:11 dr; (c) PdCl2(MeCN)2, MeCN, 82 °C; (d) (i) i-Bu2AlH, THF, 0 °C, (ii) 
1,8-diazabicyclo[5.4.0]undec-7-ene, MeOH, 21 °C; (e) Ac2O, HCO2H, pyridine, CH2Cl2, 
21 °C; (f) NaBH4, TFA, THF, 0 °C; (g) PhSH, K2CO3, DMF, 50 °C; (h) Me3SiCN, 
(F3C)2CHOH, H2O, 21 °C; p-Ns = para-nitrobenzenesulfonyl.
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Scheme 8. 
Sulfinimine Allylation Approach to Tricycle (+)-24a
aReagents and conditions: (a) allylMgBr, MgBr2, CH2Cl2, −78 °C, >98:2 dr; (b) O3, MeOH, 
−78 °C; NaBH4, −78 → 23 °C; (c) o-NsNHBoc, diisopropyl azodicarboxylate, polystyrene–
PPh3, THF, 50 °C; PhSH, Cs2CO3, 50 °C; (d) Me2C(OH)CH=CHSn(n-Bu)3, PdCl2(PPh3)2, 
PhMe, THF, 110 °C; (e) PdCl2(MeCN)2, MeCN, 80 °C; (f) (i) LiBH4, MeOH, THF, 0 → 
23 °C; (ii) Me3SiCN, (F3C)2CHOH, 0 °C; (g) HCl, dioxane, MeOH, 23 °C; (h) Sc(OTf)3, 
F3CCH2OH, 23 °C; o-Ns = ortho-nitrobenzenesulfonyl. ORTEP representation of amine 
(+)-48: thermal ellipsoids drawn at 50% probability.23
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Scheme 9. 
Directed Synthesis of Heterodimer (+)-51a
aReagents and conditions: (a) 4-(N,N-dimethylamino)pyridine, THF, 23 °C; (b) polystyrene–
2-t-butylimino-2-diethylamino-1,3-dimethyl-perhydro-1,3,2-diazaphos-phorine, N-chloro-
N-methylbenzamide, MeOH, 23 °C; (c) hν (350 nm), 25 °C.
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Scheme 10. 
Synthesis of (−)-Communesin F (1) via a Biogenetically Inspired Final Stage 
Reorganizationa
aReagents and conditions: (a) Sc(OTf)3, F3CCH2OH, 23 °C; (b) t-BuOLi, MeOH, 50 °C; dry 
PPTS, Ac2O, 23 °C; (c) Na(Hg), NaH2PO4, THF, MeOH, 23 °C.
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